U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT06930339) titled 'Portable Neuromodulation Stimulator Registry for People With Multiple Sclerosis' on March 25.
Brief Summary: The Registry will be designed to gather information over 3 years. This important health economic information will help to establish the value of the PoNS Device on key therapeutic outcomes. These outcomes will include:
disease-associated injury risks (i.e., falls), onset of new comorbidities and/or worsening/improvement of existing medical condition(s) (other than gait deficit/impairment), need for new pharmacological/non-pharmacological intervention or increase/decrease of ongoing pharmacotherapy or other non-pharmacologic...